Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2011-04-12
2011-04-12
Shafer, Shulamith H. (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S134100, C424S141100, C424S142100, C424S143100, C424S144100, C424S145100, C424S152100, C424S158100, C435S326000, C435S334000, C435S335000, C435S343200, C435S007200, C435S007210, C435S007240, C530S388150, C530S388100, C530S388230
Reexamination Certificate
active
07923011
ABSTRACT:
The invention provides various antibodies that bind to lymphotoxin-α, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell
patent: 4560655 (1985-12-01), Baker
patent: 4657866 (1987-04-01), Kumar
patent: 4676980 (1987-06-01), Segal et al.
patent: 4767704 (1988-08-01), Cleveland et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4920196 (1990-04-01), Aggarwal
patent: 4927762 (1990-05-01), Darfler
patent: 4959457 (1990-09-01), Bringman
patent: 5122469 (1992-06-01), Mather et al.
patent: 5188969 (1993-02-01), Arai et al.
patent: 5264365 (1993-11-01), Georgiou et al.
patent: 5427908 (1995-06-01), Dower et al.
patent: 5432018 (1995-07-01), Dower et al.
patent: 5498530 (1996-03-01), Schatz et al.
patent: 5500362 (1996-03-01), Robinson et al.
patent: 5508192 (1996-04-01), Georgiou et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5567610 (1996-10-01), Borrebaeck et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5571894 (1996-11-01), Wels et al.
patent: 5573905 (1996-11-01), Lerner et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5587458 (1996-12-01), King et al.
patent: 5591669 (1997-01-01), Krimpenfort et al.
patent: 5624821 (1997-04-01), Winter et al.
patent: 5641870 (1997-06-01), Rinderknecht et al.
patent: 5648237 (1997-07-01), Carter
patent: 5648260 (1997-07-01), Winter et al.
patent: 5658727 (1997-08-01), Barbas et al.
patent: 5661004 (1997-08-01), Browning et al.
patent: 5670149 (1997-09-01), Browning et al.
patent: 5683688 (1997-11-01), Aggarwal et al.
patent: 5723286 (1998-03-01), Dower et al.
patent: 5731168 (1998-03-01), Carter et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5747023 (1998-05-01), Goeddel et al.
patent: 5750373 (1998-05-01), Garrard et al.
patent: 5789199 (1998-08-01), Joly et al.
patent: 5795964 (1998-08-01), Browning et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 5824509 (1998-10-01), Aggarwal et al.
patent: 5837234 (1998-11-01), Gentile et al.
patent: 5837242 (1998-11-01), Holliger et al.
patent: 5840523 (1998-11-01), Simmons et al.
patent: 5869046 (1999-02-01), Presta et al.
patent: 5925351 (1999-07-01), Browning et al.
patent: 5969108 (1999-10-01), McCafferty et al.
patent: 6027888 (2000-02-01), Georgiou et al.
patent: 6083715 (2000-07-01), Georgiou et al.
patent: 6171586 (2001-01-01), Lam et al.
patent: 6172197 (2001-01-01), McCafferty et al.
patent: 6267958 (2001-07-01), Andya et al.
patent: 6312691 (2001-11-01), Browning et al.
patent: 6403087 (2002-06-01), Browning et al.
patent: 6528624 (2003-03-01), Idusogie et al.
patent: 6602684 (2003-08-01), Umana et al.
patent: 6669941 (2003-12-01), Browning et al.
patent: 6737056 (2004-05-01), Presta
patent: 7001598 (2006-02-01), Browning et al.
patent: 7011974 (2006-03-01), Wood et al.
patent: 7029872 (2006-04-01), Gerngross et al.
patent: 7030080 (2006-04-01), Browning et al.
patent: 7056695 (2006-06-01), Dahiyat et al.
patent: 2002/0004587 (2002-01-01), Miller et al.
patent: 2002/0039580 (2002-04-01), Browning et al.
patent: 2002/0136719 (2002-09-01), Shenoy et al.
patent: 2002/0164328 (2002-11-01), Shinkawa et al.
patent: 2002/0197254 (2002-12-01), Browning et al.
patent: 2003/0115614 (2003-06-01), Kanda et al.
patent: 2003/0157108 (2003-08-01), Presta
patent: 2003/0175884 (2003-09-01), Umana et al.
patent: 2004/0018590 (2004-01-01), Gerngross et al.
patent: 2004/0058394 (2004-03-01), Garber et al.
patent: 2004/0093621 (2004-05-01), Shitara et al.
patent: 2004/0109865 (2004-06-01), Niwa et al.
patent: 2004/0110282 (2004-06-01), Kanda et al.
patent: 2004/0110704 (2004-06-01), Yamane et al.
patent: 2004/0132140 (2004-07-01), Satoh et al.
patent: 2004/0259150 (2004-12-01), Nakamura et al.
patent: 2005/0037003 (2005-02-01), Browning et al.
patent: 2005/0123546 (2005-06-01), Umana et al.
patent: 2005/0129614 (2005-06-01), Rosen et al.
patent: 2005/0163747 (2005-07-01), Hilbert et al.
patent: 2005/0260201 (2005-11-01), Le et al.
patent: 2005/0266004 (2005-12-01), Giles-Komar et al.
patent: 2005/0271663 (2005-12-01), Ignatovich et al.
patent: 2005/0276805 (2005-12-01), Hanai et al.
patent: 2006/0025576 (2006-02-01), Miller et al.
patent: 2006/0034828 (2006-02-01), Gerngross et al.
patent: 2006/0034830 (2006-02-01), Gerngross et al.
patent: 2006/0063254 (2006-03-01), Kanda et al.
patent: 2006/0064781 (2006-03-01), Kanda et al.
patent: 2006/0067930 (2006-03-01), Adams et al.
patent: 2006/0078990 (2006-04-01), Kanda et al.
patent: 2006/0078991 (2006-04-01), Kanda et al.
patent: 2006/0121037 (2006-06-01), Le et al.
patent: 2006/0134102 (2006-06-01), LePage et al.
patent: 2006/0147448 (2006-07-01), Gommerman et al.
patent: 2006/0147452 (2006-07-01), Kang et al.
patent: 2006/0209604 (2006-09-01), Gerngross et al.
patent: 2006/0222644 (2006-10-01), Garber et al.
patent: 2006/0222646 (2006-10-01), Treacy
patent: 2007/0010009 (2007-01-01), Kanda et al.
patent: 2007/0048300 (2007-03-01), Taylor et al.
patent: 2007/0111281 (2007-05-01), Sondermann et al.
patent: 1585477 (2003-06-01), None
patent: 1539793 (2004-01-01), None
patent: 1585547 (2004-07-01), None
patent: 97/30087 (1997-08-01), None
patent: WO 99/51642 (1999-10-01), None
patent: 00/61739 (2000-10-01), None
patent: 01/29246 (2001-04-01), None
patent: 03/011878 (2003-02-01), None
patent: 03/035835 (2003-05-01), None
patent: 03/084570 (2003-10-01), None
patent: WO 2004/039329 (2004-05-01), None
patent: WO 2004/056312 (2004-07-01), None
patent: 2004/078140 (2004-09-01), None
patent: 2005/035586 (2005-04-01), None
patent: 2005/035778 (2005-04-01), None
patent: 2005/044859 (2005-05-01), None
patent: WO 2005/053742 (2005-06-01), None
patent: WO 2005/067477 (2005-07-01), None
patent: WO 2005/097832 (2005-10-01), None
patent: 2006/014679 (2006-02-01), None
patent: 2006/014683 (2006-02-01), None
patent: 2006/014685 (2006-02-01), None
patent: 2006/014725 (2006-02-01), None
patent: 2006/014726 (2006-02-01), None
patent: WO 2006/114284 (2006-11-01), None
McDevitt et al. 2002. Arthritis Res. 4(Suppl 3):S141-S152.
Schneider et al. 2004. Immunological Rev. 202:49-66.
Paul, Fundamental Immunology, 3r˜ Edition, 1993, pp. 292-295, under the heading Fv Structure and Diversity in Three Dimensions.
MacCallum et al. J. Mol. Biol. (1996) 262:732-745.
Casset et al. (2003) BBRC 307, 198-205.
Anolik et al. 2005. Best Practice and Res. Clin Rheum. 19:859-878.
Gommerman et al. 2003. Nature Rev. Immunol. 3:642-655.
Aggarwal et al., “Human Tumor Necrosis Factor”Journal of Biological Chemistry260(4) :2345-2354 (1985).
Aggarwal et al., “Lymphotoxin and Tumor Necrosis Factor: Qualitative and Quantitative Differences in Their Receptors and Signal Transduction in Various Cell Types”Cytokines and Lipocortins in Inflammation and Differentiation, Wiley-Liss, Inc. pp. 375-384 (1990).
Aggarwal, “Comparative Analysis of the Structure and Function of TNF-α and TNF-β”Tumor Necrosis Factors: Structure, Function and Mechanism of Action, Aggarwal and Vicek, eds., pp. 61-78 (1992).
Agyekum et al., “Expression of lymphotoxin-beta (LT-beta) in chronic inflammatory conditions”Journal of Pathology199(1) :115-121 (Jan. 2003).
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines, “Guidelines for the Management of Rheumatoid Arthritis”Arthritis and Rheumatism46(2) :328-346 (Feb. 2002).
American Type Culture Collection Catalogue of Cell Lines and Hybridomas, sixth edition pp. 346-349 (1988).
Androlewicz et al., “Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma”Journal of Biological Chemistry267 (4) :2542-2547 (Feb. 5, 1992).
Arie et al., “Chaperone Function of FkpA, A Heat Shock Prolyl Isomerase, in the Periplasm ofEsc
Adams Camellia W.
Grogan Jane L.
Gurney Austin L.
McCutcheon Krista
Boyd Victoria L.
Genentech Inc.
Shafer Shulamith H.
LandOfFree
Antibodies to lymphotoxin-alpha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to lymphotoxin-alpha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to lymphotoxin-alpha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2652598